Related Experiment Video
Updated: May 5, 2026
10:14
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
4.1K
MERTK-associated retinal dystrophy: clinical course and imaging
Thales A C de Guimarães1,2,3,4,5, Juan Romo-Aguas1,2, Nancy Aychoua1,2
1UCL Institute of Ophthalmology, University College London, London, UK.
Ophthalmic Genetics
|May 4, 2026
Summary
MERTK-associated retinal dystrophy is a severe inherited eye disease. Patients experience rapid vision loss, legal blindness by age 39, and early onset of symptoms like night blindness.
Area of Science:
- Ophthalmology
- Genetics
- Retinal Dystrophies
Background:
- MERTK-associated retinal dystrophy is a rare genetic disorder.
- Understanding its clinical spectrum and natural history is crucial for patient management.
Purpose of the Study:
- To analyze the clinical spectrum and natural history of MERTK-associated retinal dystrophy.
Main Methods:
- Retrospective analysis of clinical data and retinal imaging from molecularly-confirmed MERTK patients.
- Key outcome measures included age of onset, visual acuity, and retinal structural parameters.
Main Results:
- Twenty-five patients with 30 MERTK variants (6 novel) were identified.
- Symptom onset before age 16, with nyctalopia as the primary symptom.
- Rapid structural progression observed, leading to legal blindness by age 39.
Conclusions:
- MERTK-associated retinal dystrophy is a severe condition with rapid progression.
- Further prospective studies are needed to standardize evaluation and assess functional impact.
